Pay in 4 interest-free payments of $25.25 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
CAS Number: 81840-15-5
GW501516 causes impaired bone formation
is a potent and selective small molecule to activate both Oct4 and Nanog promoter-driven luciferase reporter genes
Potent activity of carfilzomib
Dactinomycin - CAS# 50-76-0 Catalog No.:M6979-10 CAS Number: 81840-15-5Dactinomycin, CAS No. 50 76 0, is the most significant member of actinomycines, which are a class of polypeptide antibiotics isolated from soil bacteria of the genus Streptomyces. As one of the older chemotherapy drugs, it has been used for many years. Actinomycin D was the first antibiotic shown to have anti cancer activity. It was first isolated by Selman Waksman and his co worker H. B. Woodruff in 1940. It was approved by the US FDA on December 10,
US$ 23.00
US$ 19.00
US$ 23.00